Abivax S.A. (ABVX)
NASDAQ·Healthcare·Biotechnology
$110.71
-1.06%
Mkt Cap $7.19B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $1.80M | $509.43K | -71.75% | -$1.07 | -$1.22 | -13.62% | — | — |
| Q3 2025 Sep 8, 2025 | $1.39M | $2.37M | +70.56% | -$0.90 | -$0.86 | +4.44% | — | — |
| Q1 2025 Mar 24, 2025 | $3.11M | $7.66M | +146.20% | -$0.68 | -$1.55 | -128.04% | — | — |
| Q4 2024 Nov 7, 2024 | $3.41M | $3.65M | +7.05% | -$1.28 | -$0.70 | +45.50% | — | — |
| Q2 2024 Apr 2, 2024 | $2.47M | $2.56M | +3.70% | -$0.91 | -$1.94 | -112.73% | — | — |
| Q2 2023 Jun 30, 2023 | — | $2.45M | — | — | -$1.58 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $2.42M | — | -$1.93 | -$1.95 | -0.81% | — | — |
| Q2 2022 Jun 30, 2022 | — | $2.33M | — | — | -$1.84 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$1.68 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$1.34 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$1.90 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$1.42 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$1.53 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$1.57 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | $385.95K | — | — | -$0.98 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $571.13K | — | — | -$0.84 | — | — | — |
| Q4 2017 Dec 31, 2017 | — | $413.00K | — | — | -$0.66 | — | — | — |
| Q2 2017 Jun 30, 2017 | — | $4.56K | — | — | -$0.65 | — | — | — |
| Q4 2016 Dec 31, 2016 | — | $14.69K | — | — | -$0.64 | — | — | — |
| Q2 2016 Jun 30, 2016 | — | $152.27K | — | — | -$0.95 | — | — | — |